Business

Indian Pharma Industry Sees Robust Sustainable Growth And Innovation In 2024

The Indian pharma industry has established itself as a key driver of knowledge for the nation’s economy. With this, the industry is estimated to be US$58 billion, with equal contributions from exports and the domestic market.

Indian pharma is a manufacturing hub of the world with a 20% contribution to global generics sales. With this year ending, there has been robust sustainable growth and a thrust on simplifying regulations and harmonisation with global standards.

Sustainable Growth & Policy Reforms in 2024

The year 2024 has proven to be a turning point for the Indian pharma sector. Building on its strong foundation, the industry has focused on achieving sustainable growth. A key aspect of this growth has been the government’s efforts to simplify regulations and align with global standards.

Notably, the Production Linked Incentive (PLI) schemes have already begun showing positive results, with new green-field projects for the production of Penicillin G and Clavulanic acid, among others. This is vital for enhancing healthcare security and ensuring a diversified supply chain.

Fostering Innovation And R&D Investment

Looking ahead, innovation will continue to be a central theme in India’s pharmaceutical growth. The government is expected to soon announce the operational details of its Promotion of Research & Innovation Programme.

It is designed to spur innovation across the sector. Companies are increasingly focusing on speciality portfolios and diversifying into high-value drugs. Products such as Nafithromycin and Saroglitazar are set to lead the charge in India’s research wave, with government-led committees dedicated to streamlining regulatory reforms that will create a more conducive environment for R&D.

Looking ahead, the Indian pharmaceutical market is expected to grow significantly, with projections indicating it will reach US$120-130 billion by 2030, up from the current size of US$58 billion.

The continued focus on quality, innovation, and expanding global reach will help India’s pharmaceutical sector unlock its full potential. With favourable policies, India is set to play a pivotal role in advancing global healthcare for years to come.

Also Read: India’s IPO Market Achieves Historic Milestone In 2024

Purnima Mishra

Recent Posts

Voyager 1 Travels 25.9 Billion Kilometres, Continues Sending Data From Interstellar Space

NASA’s Voyager 1 spacecraft, launched in 1977 for a mission lasting just four to five…

4 hours ago

Muslims Projected To Surpass Christians As World’s Largest Religious Group By 2035

Muslims are projected to become the world’s largest religious group by 2035, with population growth…

4 hours ago

PM Modi Meets Prince William And Kate, Reaffirms India-UK Strategic Partnership

Prime Minister Narendra Modi met Prince William and Princess Kate in New Delhi, discussed strengthening…

4 hours ago

PM Modi’s Manila Gurdwara Engagement Highlighted India’s Outreach To Sikh Community

Prime Minister Narendra Modi attended the redevelopment launch of Gurdwara Khalsa Diwan in Manila during…

5 hours ago

‘Jai Chhathi Maiya’ Echoed In London As Anil Agarwal Celebrated Chhath With Indian Diaspora

Vedanta Chairman Anil Agarwal joined Chhath Puja celebrations in London, where hundreds of devotees observed…

5 hours ago

Keralam Chief Minister VD Satheesan Meets Prime Minister Narendra Modi

Keralam Chief Minister VD Satheesan met Prime Minister Modi in New Delhi, marking a meeting…

6 hours ago